FibroBiologics, GLP-1, GIP, GLP-2, Therapeutic Peptides, Cell Therapy, Engineered Cells, Organoids, Spheroids, Biotechnology, Patent Application, Drug Delivery, Metabolic Disorders

HOUSTON, October 7, 2026 FibroBiologics, Inc. (Nasdaq: FBLG), a clinical-stage biotechnology company developing treatments for chronic diseases using fibroblasts...